DalsnaFinance › Analyst accuracy › Guggenheim › ABBV target

Guggenheim’s $288 target on ABBV

ABBV AbbVie
$244 → $288 (+18%) by Aug 2027
Buy · raises · said Aug 4, 2026 · 12-month default horizon
Open: judged on the close on Aug 4, 2027

The article this target came from

ABBV Maintained by Guggenheim -- Price Target Raised to $288

GuruFocus · Aug 4, 2026
ABBV Maintained by Guggenheim -- Price Target Raised to $288

A fact about what Guggenheim published, as reported by GuruFocus, not a recommendation from Dalsna Finance; Guggenheim is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.